Integrative Approaches for Cancer Survivorship (IACS3)

Eligibility Criteria

• 1. Age \>= 18
• 2. Able to understand study procedures and to comply with them for the entire length of the study.
• 3. Able to read, write, and understand English.
• 4. Ability of individual or legal guardian/representative to understand a verbal informed consent document, and the willingness to sign it.
• 5. Non-metastatic breast cancer patients who are between 1 and 36 months after completion of primary treatment (i.e., surgery, radiotherapy, chemotherapy) and are in a complete remission.
• 6. Participants should have received chemotherapy as part of their primary treatment.
• 7. Have an impaired quality of life (report a score of 5 or less on question 30 of the European Organisation for Research and Treatment of Cancer Quality of Life Cancer questionnaire (EORTC-QLQ-C30). "How would you rate your overall quality of life during the past week?"
• 8. Karnofsky Performance Status Score (KPS) \>=60
• 1. Contraindication to any study-related procedure or assessment.
• 2. Metastatic disease and receiving chemotherapy or radiotherapy at the time of study enrollment (participants with non-metastatic disease who are receiving anti-Her2 directed treatment alone in the adjuvant setting are eligible).
• 3. Participants are within 1 month after surgery for cancer, including breast reconstructive surgery but not including implant exchange.
• 4. Cancer surgery planned during the initial 6-month study period.
• 5. Been on adjuvant hormone therapy (for breast cancer) less than 2 months at the time of enrollment.
• 6. Received Ayurvedic treatment during the 3 months preceding enrollment.
• 7. Severe depression assessed by the Patient Health Questionnaire Depression scale (PHQ-8) using a cutoff score of 20 or higher or severe anxiety assessed by the Generalized Anxiety Disorder Questionnaire (GAD-7) using a cutoff score of 15 or higher.